131 related articles for article (PubMed ID: 25675803)
1. TGF-β expression in vulvar cancer.
Karoń P; Olejek A; Olszak-Wasik K
Ginekol Pol; 2014 Nov; 85(11):847-51. PubMed ID: 25675803
[TBL] [Abstract][Full Text] [Related]
2. Occult lymph node metastases in early stage vulvar carcinoma patients.
Knopp S; Holm R; Tropé C; Nesland JM
Gynecol Oncol; 2005 Nov; 99(2):383-7. PubMed ID: 16051338
[TBL] [Abstract][Full Text] [Related]
3. Pathologic evaluation of inguinal sentinel lymph nodes in vulvar cancer patients: a comparison of immunohistochemical staining versus ultrastaging with hematoxylin and eosin staining.
Moore RG; Granai CO; Gajewski W; Gordinier M; Steinhoff MM
Gynecol Oncol; 2003 Nov; 91(2):378-82. PubMed ID: 14599869
[TBL] [Abstract][Full Text] [Related]
4. Cytokine, cell adhesion receptor, and tumor suppressor gene expression in vulvar squamous carcinoma: correlation with prominent fibromyxoid stromal response.
Ambros RA; Kallakury BV; Malfetano JH; Mihm MC
Int J Gynecol Pathol; 1996 Oct; 15(4):320-5. PubMed ID: 8886879
[TBL] [Abstract][Full Text] [Related]
5. Expression of epithelial growth factor receptor and its two ligands, transforming growth factor-alpha and epithelial growth factor, in normal and neoplastic squamous cells in the vulva: an immunohistochemical study.
Wu X; Xin Y; Yao J; Hasui K; Tsuyama S; Yonezawa S; Murata F
Med Electron Microsc; 2001 Sep; 34(3):179-84. PubMed ID: 11793194
[TBL] [Abstract][Full Text] [Related]
6. EGFR expression is associated with groin node metastases in vulvar cancer, but does not improve their prediction.
Oonk MH; de Bock GH; van der Veen DJ; Ten Hoor KA; de Hullu JA; Hollema H; van der Zee AG
Gynecol Oncol; 2007 Jan; 104(1):109-13. PubMed ID: 16963112
[TBL] [Abstract][Full Text] [Related]
7. The expression of galectin-1 in vulvar neoplasia.
Kohrenhagen N; Voelker HU; Kapp M; Dietl J; Kämmerer U
Anticancer Res; 2010 May; 30(5):1547-52. PubMed ID: 20592339
[TBL] [Abstract][Full Text] [Related]
8. Detection of lymphovascular invasion in vulvar cancer by D2-40 (podoplanin) as a predictor for inguinal lymph node metastases.
Braun M; Wardelmann E; Debald M; Walgenbach-Bruenagel G; Höller T; Wolfgarten M; Sauerwald A; Rudlowski C; Büttner R; Kuhn W; Pölcher M
Onkologie; 2009 Dec; 32(12):732-8. PubMed ID: 20016234
[TBL] [Abstract][Full Text] [Related]
9. High levels of p53 expression correlate with DNA aneuploidy in (pre)malignancies of the vulva.
van der Avoort IA; van de Nieuwenhof HP; Otte-Höller I; Nirmala E; Bulten J; Massuger LF; van der Laak JA; Slootweg PJ; de Hullu JA; van Kempen LC
Hum Pathol; 2010 Oct; 41(10):1475-85. PubMed ID: 20656324
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 and CD1a-positive dendritic cells are involved in the development of an invasive phenotype in vulvar squamous lesions.
Brustmann H
Int J Gynecol Pathol; 2006 Jan; 25(1):30-7. PubMed ID: 16306781
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor (VEGF) in vulvar squamous cancer and VIN.
Lewy-Trenda I; Wierzchniewska-ławska A; Papierz W
Pol J Pathol; 2005; 56(1):5-8. PubMed ID: 15921007
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance and prognostic value of femoral lymph node metastasis in FIGO stage III vulvar carcinoma.
Tu H; Sun P; Gu HF; Zhang XK; Huang H; Wan T; Liu JH
Eur J Surg Oncol; 2017 Sep; 43(9):1768-1775. PubMed ID: 28602173
[TBL] [Abstract][Full Text] [Related]
13. Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.
Polterauer S; Schwameis R; Grimm C; Hillemanns P; Jückstock J; Hilpert F; de Gregorio N; Hasenburg A; Sehouli J; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Harter P; Wimberger P; Kölbl H; Reinthaller A; Woelber L; Mahner S
Gynecol Oncol; 2019 May; 153(2):286-291. PubMed ID: 30760408
[TBL] [Abstract][Full Text] [Related]
14. Expression of cell-cycle-associated proteins pRB2/p130 and p27kip in vulvar squamous cell carcinomas.
Zamparelli A; Masciullo V; Bovicelli A; Santini D; Ferrandina G; Minimo C; Terzano P; Costa S; Cinti C; Ceccarelli C; Mancuso S; Scambia G; Bovicelli L; Giordano A
Hum Pathol; 2001 Jan; 32(1):4-9. PubMed ID: 11172288
[TBL] [Abstract][Full Text] [Related]
15. The role of cofilin-l in vulvar squamous cell carcinoma: A marker of carcinogenesis, progression and targeted therapy.
Wu Q; Jiang Y; Cui S; Wang Y; Wu X
Oncol Rep; 2016 May; 35(5):2743-54. PubMed ID: 26936386
[TBL] [Abstract][Full Text] [Related]
16. In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases.
Emanuels AG; Koudstaal J; Burger MP; Hollema H
Br J Cancer; 1999 Apr; 80(1-2):38-43. PubMed ID: 10389975
[TBL] [Abstract][Full Text] [Related]
17. Association of CXC chemokine receptor type 4 expression and clinicopathologic features in human vulvar cancer.
Shiozaki T; Tabata T; Ma N; Yamawaki T; Motohashi T; Kondo E; Tanida K; Okugawa T; Ikeda T
Int J Gynecol Cancer; 2013 Jul; 23(6):1111-7. PubMed ID: 23765204
[TBL] [Abstract][Full Text] [Related]
18. Screening for occult nodal metastasis in squamous cell carcinoma of the vulva.
Leys CM; Hartenbach EM; Hafez GR; Mahvi DM
Int J Gynecol Pathol; 2000 Jul; 19(3):243-7. PubMed ID: 10907173
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of thrombospondin-1 in invasive vulvar squamous cell carcinoma.
Tringler B; Grimm C; Sliutz G; Leodolter S; Speiser P; Reinthaller A; Hefler LA
Gynecol Oncol; 2005 Oct; 99(1):80-3. PubMed ID: 16009408
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of E-cadherin and β-catenin in the vulvar squamous cell carcinoma tissues].
Jia L; Ouyang L; Zhou Y; Song ZX; Tong X; Li B; Zhang ST; He Z
Zhonghua Fu Chan Ke Za Zhi; 2013 Jun; 48(6):437-41. PubMed ID: 24103123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
